Metastatic Colorectal Cancers Terminated Phase 2 Trials for Capecitabine (DB01101)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01668680Maintenance Metronomic Chemotherapy for Metastatic Colorectal CarcinomaTreatment
NCT03645876SHR-1210 in Combination With BP102 and XELOX in Patient With Metastatic Colorectal CancerTreatment
NCT00459901Study of the Antitumor Activity of Capecitabine in Combination With Erlotinib in Patients With Metastatic Colorectal CancerTreatment
NCT00717990Irinotecan, Capecitabine and Avastin for Metastatic Colorectal Cancer as Salvage TreatmentTreatment
NCT00961571Sunitinib and Capecitabine for First Line Colon CancerTreatment
NCT01718808Cetuximab for Elderly Patients With mCRCTreatment